Investor Relations
Corporate Profile
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.
Stock Quote
Data Provided by Refinitiv. Minimum 15 minutes delayed.